Skip to main content
Signal8

FNA (FNA)

Paragon 28, Inc. logo

Paragon 28, Inc.

NYSE:FNAHealthcare
Mkt Cap-
Float44.19M
O/S-
Inst Own-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE
CountryUSUS
IPO DateOct 15, 2021
Shares Outstanding-
Float44.19M
Company Overview

Paragon 28, Inc. is a medical device company specializing in the development, manufacturing, and global distribution of advanced surgical systems tailored for foot and ankle procedures.

Its comprehensive product portfolio encompasses a wide array of solutions: Plating Systems: This includes the Gorilla plating series, offering specific solutions for Lisfranc injuries, Lapidus procedures, lateral column corrections, calcaneus slides, and naviculocuneiform (NC) fusions. Complementary products like Baby Gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates, as well as Silverback plating systems, are also available. Precision Guidance Technology: The company provides sophisticated guidance systems to enhance accuracy in various operations, such as fusion procedures for bunion deformities, first tarsometatarsal arthrodesis, metatarsal osteotomy for bunion correction, medial column beaming for Charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. Screw Systems: Paragon 28 offers robust screw systems, including the Monster, Mini Monster, and Joust beaming lines, which are critical for applications like bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, and fracture repair. Joint Replacement Solutions: Their offerings extend to total ankle replacement with the APEX 3D systems, alongside total talus spacers designed to replace the talus bone that links the leg and foot. Bunion/Hallux Valgus Correction Systems: Specifically for bunion management, the company provides nail systems such as the Phantom intramedullary nail systems, targeting severe hallux valgus cases. Orthobiologics: A substantial part of their product line comprises various orthobiologics, including bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix. They also feature PRESERVE bone graft systems for homologous applications. Ancillary Products: The company further supplies soft tissue fixation systems, titanium sprayed polyetheretherketone (PEEK) implants, nitinol staple systems, stabilization solutions, and specialized curved instruments. Paragon 28 distributes its products to hospitals and ambulatory surgery centers through an established network of both direct sales representatives and stocking distributors. Founded in 2010, the company maintains its corporate headquarters in Englewood, Colorado.

Leadership

Albert DaCosta

Co-Founder, Chairman, President & Chief Executive Officer

Drew Hill

Executive Vice President of Research and Development

Erik Mickelson

Chief Accounting Officer and Controller

Kristina Wright

Interim Chief Financial Officer, Director

Employees

525

Country

US

Sector

Healthcare

Website

paragon28.com

Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
No price targets available
Ratings Distribution
BUY
3
HOLD
4
SELL
0
TOTAL7
Insider Trades
InsiderTypeShares
McCormack Robert S profile photoMcCormack Robert SWithholding/Transfer203.1K
Scanlon Meghan profile photoScanlon MeghanWithholding/Transfer42.1K
SCHNETTLER THOMAS P profile photoSCHNETTLER THOMAS PWithholding/Transfer45.0K
Oesterle Stephen N. profile photoOesterle Stephen N.Withholding/Transfer40.2K
JOHNSON B KRISTINE profile photoJOHNSON B KRISTINEWithholding/Transfer47.3K
Jarboe Matthew profile photoJarboe MatthewWithholding/Transfer575.3K
Shareholders
--
Institutional
(1)
--
Insiderⓘ
(7)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F, Form 4
Insiders & Institutional Holders

Insiders

Top institutional holders

52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

--

90d Avg

--

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...